Francesco Di Virgilio Selected Research

Monoclonal Antibodies

7/2021

The P2X7 Receptor: A Promising Pharmacological Target in Diabetic Retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Di Virgilio Research Topics

Disease

46	Neoplasms (Cancer) 01/2023 - 02/2005
37	Inflammation (Inflammations) 05/2023 - 03/2003
8	Infections 01/2024 - 12/2003
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2012
5	Neuroinflammatory Diseases 12/2023 - 12/2017
4	Pneumonia (Pneumonitis) 07/2018 - 08/2007
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017 - 01/2002
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
3	Lung Diseases (Lung Disease) 05/2017 - 08/2008
3	Chronic Obstructive Pulmonary Disease (COPD) 03/2011 - 05/2010
2	Virus Diseases (Viral Diseases) 01/2024 - 01/2020
2	Fever (Fevers) 01/2023 - 07/2012
2	COVID-19 01/2023 - 11/2020
2	Carcinogenesis 01/2022 - 02/2009
2	Disease Progression 01/2022 - 01/2017
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 08/2019
2	Neoplasm Metastasis (Metastasis) 12/2021 - 11/2021
2	Malignant Mesothelioma 01/2021 - 08/2016
2	Leukemia 01/2020 - 01/2017
2	Neuroblastoma 01/2020 - 01/2006
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2017 - 01/2017
2	Fibrosis (Cirrhosis) 05/2017 - 01/2017
2	Lung Injury 01/2017 - 07/2010
2	Tuberculosis (Tuberculoses) 12/2013 - 11/2006
2	Pain (Aches) 01/2013 - 07/2012
2	Necrosis 01/2013 - 12/2012
2	Emphysema 03/2011 - 07/2010
2	Bacterial Infections (Bacterial Infection) 11/2006 - 01/2006
1	Hypoxia (Hypoxemia) 01/2024
1	Conjunctivitis 08/2023
1	Lymphopenia (Lymphocytopenia) 01/2023
1	Brain Diseases (Brain Disorder) 10/2022
1	Stroke (Strokes) 10/2022
1	Insulin Resistance 03/2022
1	Intervertebral Disc Degeneration 01/2022
1	Blindness (Hysterical Blindness) 07/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2021

Drug/Important Bio-Agent (IBA)

50	Adenosine Triphosphate (ATP)IBA 01/2023 - 04/2003
33	Purinergic P2X7 ReceptorsIBA 05/2023 - 01/2002
15	Purinergic Receptors (Receptors, Purine)IBA 01/2023 - 11/2006
14	CytokinesIBA 01/2023 - 04/2003
13	NucleotidesIBA 12/2023 - 03/2003
8	InflammasomesIBA 08/2023 - 07/2010
5	Interleukin-6 (Interleukin 6)IBA 08/2023 - 01/2019
5	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 11/2012
5	Proteins (Proteins, Gene)FDA Link 07/2018 - 07/2003
4	Purinergic P2 Receptors (ADP Receptor)IBA 10/2022 - 03/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 06/2012
4	Uridine Triphosphate (UTP)IBA 01/2020 - 07/2003
3	AntigensIBA 01/2024 - 08/2007
3	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2014
3	purineIBA 01/2021 - 01/2018
3	LipopolysaccharidesIBA 07/2018 - 11/2006
2	NucleosidesIBA 12/2023 - 01/2020
2	LigandsIBA 12/2023 - 01/2018
2	PurinesIBA 01/2023 - 11/2012
2	Ion Channels (Ion Channel)IBA 01/2023 - 01/2021
2	InterleukinsIBA 01/2022 - 01/2020
2	(N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)- 2,2- dimethylpropyl)- 2- (3,4- dimethoxyphenyl)acetamide)IBA 12/2021 - 01/2019
2	Bevacizumab (Avastin)FDA Link 07/2021 - 06/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2021 - 01/2019
2	denatonium (denatonium benzoate)IBA 01/2021 - 01/2020
2	AZ10606120IBA 01/2021 - 08/2016
2	NucleotidasesIBA 11/2020 - 01/2020
2	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2020 - 01/2017
2	EnzymesIBA 01/2020 - 01/2011
2	Adenosine Diphosphate (ADP)IBA 01/2020 - 02/2002
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 06/2019 - 07/2010
2	Bleomycin (Blenoxane)FDA LinkGeneric 05/2017 - 01/2017
2	LuciferasesIBA 02/2015 - 07/2008
2	Apyrase (ATP Diphosphatase)IBA 12/2013 - 08/2007
2	SmokeIBA 03/2011 - 07/2010
2	EndotoxinsIBA 11/2006 - 10/2004
1	ChromatinIBA 01/2024
1	ProcalcitoninIBA 01/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	Single-Domain AntibodiesIBA 10/2022
1	salicylhydroxamic acid (SHAM)IBA 10/2022
1	Insulin (Novolin)FDA Link 03/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA 01/2022
1	Viral AntigensIBA 12/2021
1	Methylnitronitrosoguanidine (MNNG)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	MicroRNAs (MicroRNA)IBA 11/2021
1	Monoclonal AntibodiesIBA 07/2021
1	Ranibizumab (Lucentis)FDA Link 07/2021
1	Hormones (Hormone)IBA 07/2021
1	Biological FactorsIBA 05/2021

Therapy/Procedure

20	Therapeutics 01/2023 - 10/2004
2	Intravenous Injections 10/2022 - 12/2012
2	Drug Therapy (Chemotherapy) 01/2017 - 11/2016
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Caloric Restriction 01/2022